To explore the clinical impact of PCAF–ISX–BRD4 signals in lung cancer, 157 paired NSCLC tumor samples (tumors along with neighboring healthy lung tissues) were obtained and analyzed. This evidence concerns the gene BRD4 and lung carcinoma.